RESUMO
The coronavirus disease 2019 (COVID-19) pandemic has introduced attention to request for various diagnostic strategies, comparative validation of novel tests, quicker federal agency clearance, and quick manufacture of test kits to satisfy worldwide demand. Thus, this study was aimed to investigate biochemical and hematological variables in COVID-19 positive patients, so as to act early and improve patient outcomes. 34 patients with COVID-19 patients were diagnosed at Rifai General Hospital, Dhi Qar Health Directorate, during the period of (15 September 2020 to March 2021) in this study with two study group, as group one (i.e. the first week infection) and group two (i.e. the second week infection). The reagents kits for Random Blood Sugar (RBS) were used, and also urea, and creatinine measurements were done by spectrophotometry method (Biolabo/France), whereas D-dimer measurement was performed by)MAGLUMI 1000-China), Complete Blood Count measurement was conducted by XP-300™ Automated Hematology Analyzer System Device, USA. In this study, it was found that WBC had a significant difference (p-value 0.05) based on the comparison between the two groups, whereas RBS and creatinine had no significant difference (p-value>0.05) and urea and D-dimer had a significant difference (p-value 0.05) when compared between the two groups. The D-dimer and urea levels were significantly increased in the second group compared with the first group of the patients. Copyright © 2023 by SPC (Sami Publishing Company)
RESUMO
Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected 86,468,659 people around the globe until 6/1/2021, with 1,869,808 mortalities. It is estimated that people with congestiveheart failure (CHF) are in a high risk category for mortality. Furthermore, persons with obesity who become ill and require intensive care present challenges in patient management as it is more difficult to intubate these persond, and this is especially true in Saudi Arabia and the region of Hail, where morbid obesity is at 33.6% of the population. Our aim is to establish an epidimiological link for our population between diabetes, obesity and percentage of intubated patients as we measured mortalities and readmissions in 30 days. Methods: A retrospective cohort study of 751 patients admitted as positive COVID 19 patients, from April 1, 2020 to July 31, 2020, covering a period of 4 months. We then categorised the patient in cohorts accordind to the existence of CHF or not, and categorised them according to their BMI index. We then correlated using statistical tool analysis - SPSS statistics tool - intubation, mortality,readmitance in 30 days in thes groups of patients Results: Around 12% of our cases were CHF. 16% of these cases intubated, instead of 5% of non CHF cases. Mortalities were higher in the CHF group as percentage ( 72% to 7%), and readmissions. Significant correlation between BMI and days of ICU stay in the CHF group Conclusions: There is significantly elevated morbidity and mortality at obese CHF cases with COVID 19
RESUMO
Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected 86,468,659 people around the globe until 6/1/2021, with 1,869,808 mortalities. It is estimated that people with diabetes melitus are, due to the hyperglycaemia, in a high risk category for mortality. Furthermore, persons with obesity who become ill and require intensive care present challenges in patient management as it is more difficult to intubate patients with obesity, andthis is especially true in Saudi Arabia and the region of Hail, where morbid obesity is at 33.6 5 of the population. Our aim is to establish an epidimiological link for our population between diabetes, obesity and percentage of intubated patients as we measured mortalities and readmissions in 30 days. Methods: A retrospective cohort study of 751 patients admitted as positive COVID 19 patients, from April 1, 2020 to July 31, 2020, covering a period of 4 months. We then categorised the patient in cohorts accordind to the existence of diabetes melitus or not, and categorised them according to their BMI index. We then correlated using statistical tool analysis - SPSS statistics tool - intubation, mortality,readmitance in 30 days in thes groups of patients Results: Around 40% of our cases were diabetic. 18% of the diabetic cases intubated, instead of 7% of non DM cases. Mortalities were higher in the diabetic group as percentage ( 14% to 7%), and readmissions. Significant correlation between BMI and days of ICU stay Conclusions: There is sigificant morbidity in DM patients with COVID 19, especially morbid obese.
RESUMO
Background and Aims: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, has infected 86,468,659 people around the globe until 6/1/2021, with 1,869,808 mortalities. It is estimated that people with ischemic heart disease (IHD) are in a high risk category for mortality. Furthermore, persons with obesity who become ill and require intensive care present challenges in patient management as it is more difficult to intubate patients with obesity, especially in Saudi Arabia and the region of Hail, where morbid obesity is at 33.6% of the population. Our aim is to establish an epidimiological link for our population between ischemic heart disease and obesity and percentage of intubated patients as we measured mortalities and readmissions in 30 days. Methods: A retrospective cohort study of 751 patients admitted as positive COVID 19 patients, from April 1, 2020 to July 31, 2020, covering a period of 4 months. We then categorised the patient in cohorts accordind to the existence of IHD or not, and categorised them according to their BMI index. We then correlated using statistical tool analysis - SPSS statistics tool - intubation, mortality,readmitance in 30 days in these groups of patient Results: Around 10% of our cases were ischemic heart disease (IHD). 15% of the IHD cases were intubated, instead of 7% of non IHD cases. Mortalities were higher in the IHD group as percentage ( 11% to 9%), and readmissions. Significant correlation between BMI and days of ICU stay Conclusions: IHD patients with COVID 19 are more critical, especially morbid obese.